Supreme Court Mulls Review Of Case On Antitrust Law In Drug Patent Settlements
In a closely watched controversy over patent settlements and antitrust law, drug makers Abbott Laboratories and Sandoz have urged the Supreme Court not to review a ruling that upholds the right...To view the full article, register now.
Already a subscriber? Click here to view full article